Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

France-Based Wandercraft Establishes New York City U.S. Headquarters

12/15/2023
French-based Wandercraft, a developer of the world's first in market self-stabilizing exoskeleton, established its U.S. headquarters at Cure, a healthcare innovation campus in New York, New York.

The company received clearance from the U.S. Food and Drug Administration in early 2023 for its lead product, the hands-free Atalante X™ exoskeleton, for use in stroke rehabilitation.

"Wandercraft's new experiential space at Cure immerses us in the heart of the world's largest healthcare market and moves us closer to achieving our goal of creating new standards of care, recovery and movement for patients with severe mobility issues due to injury or illness," said Matthieu Masselin, CEO of Wandercraft. "Cure enhances our ability to collaborate with leading research institutions and other cutting-edge entrepreneurs, while applying our strong clinical and engineering expertise to create state-of-the-art robotic exoskeleton technologies that improve patients' clinical and functional outcomes."

The Cure campus offers residents opportunities to create synergies and collaborative partnerships with peer organizations that span medical technology, healthcare services, therapeutics, healthcare investment, academic research and non-profit initiatives.

"Wandercraft's technology, which masterfully combines its expertise in biomechanics engineering and neurobiology, exemplifies the innovative approaches that Cure residents are bringing to the healthcare ecosystem," noted Seema Kumar, CEO of Cure. "By joining our community, Wandercraft also furthers Cure's mission to convene healthcare innovators and foster meaningful collaborations among organizations that span disciplines, sectors and geographies."

Wandercraft developed Atalante X with a proprietary self-balancing feature that enables patients to move in multiple directions without using their hands or an assistive device. Atalante X includes a dynamic Active Balance mode, unavailable elsewhere in the exoskeleton market, that leverages a motion sensor on the patient's back to enable the exoskeleton to follow the patient's movements.

Exclusive Research